New publication by Hentzen et al. in Journal of Surgical Oncology

The manuscript entitled: ‘Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review’ can be found here.

Abstract

Patients with peritoneal carcinomatosis (PC) from colorectal origin may undergo cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as a curative approach. One major prognostic factor that affects survival is completeness of cytoreduction. Molecular Fluorescence Guided Surgery (MFGS) is a novel intraoperative imaging technique that may improve tumor identification in the future, potentially preventing over- and under-treatment in these patients. This narrative review outlines a chronological overview of MFGS development in patients with PC of colorectal origin.

 

 

Citation: J.E.K.R. Hentzen, S.J. De Jongh, P.H.J. Hemmer, et al. Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review. J Surg Oncol. 2018 Aug;118(2):332-343. doi: 10.1002/jso.25106. Epub 2018 Jun 24. PMID: 29938400; PMCID: PMC6174973.